304 related articles for article (PubMed ID: 559700)
1. On the mechanism of cell membrane damage by complement: evidence on insertion of polypeptide chains from C8 and C9 into the lipid bilayer of erythrocytes.
Hammer CH; Shin ML; Abramovitz AS; Mayer MM
J Immunol; 1977 Jul; 119(1):1-8. PubMed ID: 559700
[TBL] [Abstract][Full Text] [Related]
2. On the mechanism of cytolysis by complement: evidence on insertion of C5b and C7 subunits of the C5b,6,7 complex into phospholipid bilayers of erythrocyte membranes.
Hammer CH; Nicholson A; Mayer MM
Proc Natl Acad Sci U S A; 1975 Dec; 72(12):5076-80. PubMed ID: 1061092
[TBL] [Abstract][Full Text] [Related]
3. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9.
Rollins SA; Sims PJ
J Immunol; 1990 May; 144(9):3478-83. PubMed ID: 1691760
[TBL] [Abstract][Full Text] [Related]
4. Proteolysis of the monomeric and dimeric C5b-9 complexes of complement: alteration in the susceptibility to proteases of the C9 subunits associated with C5b-9 dimerization.
Yamamoto K; Migita S
J Immunol; 1981 Aug; 127(2):423-6. PubMed ID: 7019323
[TBL] [Abstract][Full Text] [Related]
5. Measurement of the ratio of the eighth and ninth components of human complement on complement-lysed membranes.
Stewart JL; Monahan JB; Brickner A; Sodetz JM
Biochemistry; 1984 Aug; 23(18):4016-22. PubMed ID: 6487588
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.
Rollins SA; Zhao J; Ninomiya H; Sims PJ
J Immunol; 1991 Apr; 146(7):2345-51. PubMed ID: 1706395
[TBL] [Abstract][Full Text] [Related]
7. C5b-9 assembly: average binding of one C9 molecule to C5b-8 without poly-C9 formation generates a stable transmembrane pore.
Bhakdi S; Tranum-Jensen J
J Immunol; 1986 Apr; 136(8):2999-3005. PubMed ID: 3958488
[TBL] [Abstract][Full Text] [Related]
8. Transmembrane channel-formation by five complement proteins.
Müller-Eberhard HJ
Biochem Soc Symp; 1985; 50():235-46. PubMed ID: 2428370
[TBL] [Abstract][Full Text] [Related]
9. Complement pores in erythrocyte membranes. Analysis of C8/C9 binding required for functional membrane damage.
Sims PJ
Biochim Biophys Acta; 1983 Aug; 732(3):541-52. PubMed ID: 6871214
[TBL] [Abstract][Full Text] [Related]
10. Species-restricted target cell lysis by human complement: complement-lysed erythrocytes from heterologous and homologous species differ in their ratio of bound to inserted C9.
Hu VW; Shin ML
J Immunol; 1984 Oct; 133(4):2133-7. PubMed ID: 6470486
[TBL] [Abstract][Full Text] [Related]
11. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
[TBL] [Abstract][Full Text] [Related]
12. The terminal membrane C5b-9 complex of human complement. Evidence for the existence of multiple protease-resistant polypeptides that form the trans-membrane complement channel.
Bhakdi S; Tranum-Jensen J; Klump O
J Immunol; 1980 May; 124(5):2451-7. PubMed ID: 6154104
[TBL] [Abstract][Full Text] [Related]
13. The membrane attack complex of complement: C5b-8 complex as accelerator of C9 polymerization.
Tschopp J; Podack ER; Müller-Eberhard HJ
J Immunol; 1985 Jan; 134(1):495-9. PubMed ID: 3964819
[TBL] [Abstract][Full Text] [Related]
14. On the cause and nature of C9-related heterogeneity of terminal complement complexes generated on target erythrocytes through the action of whole serum.
Bhakdi S; Tranum-Jensen J
J Immunol; 1984 Sep; 133(3):1453-63. PubMed ID: 6747293
[TBL] [Abstract][Full Text] [Related]
15. The modifications of the final stages of the complement reaction by alkali metal cations.
Dalmasso AP; Lelchuk R; Giavedoni EB; De Isola ED
J Immunol; 1975 Jul; 115(1):63-8. PubMed ID: 239058
[TBL] [Abstract][Full Text] [Related]
16. Studies of the association of the eighth and ninth components of human complement within the membrane-bound cytolytic complex.
Monahan JB; Stewart JL; Sodetz JM
J Biol Chem; 1983 Apr; 258(8):5056-62. PubMed ID: 6833292
[TBL] [Abstract][Full Text] [Related]
17. Distinction between C8-mediated and C8/C9-mediated hemolysis on the basis of independent 86Rb and hemoglobin release.
Gee AP; Boyle MD; Borsos T
J Immunol; 1980 Apr; 124(4):1905-10. PubMed ID: 7365242
[TBL] [Abstract][Full Text] [Related]
18. Multimeric C9 within C5b-9 deposits in unique locations in the cell wall of Salmonella typhimurium.
Joiner KA; Tartanian AB; Hammer CH; Schweinle JE
J Immunol; 1989 Jun; 142(12):4450-7. PubMed ID: 2656866
[TBL] [Abstract][Full Text] [Related]
19. Studies on the terminal stages of immune hemolysis. III. Distinction between the insertion of C9 and the formation of a transmembrane channel.
Boyle MD; Langone JJ; Borsos T
J Immunol; 1978 May; 120(5):1721-25. PubMed ID: 659873
[TBL] [Abstract][Full Text] [Related]
20. Complement-mediated killing of the Lyme disease spirochete Borrelia burgdorferi. Role of antibody in formation of an effective membrane attack complex.
Kochi SK; Johnson RC; Dalmasso AP
J Immunol; 1991 Jun; 146(11):3964-70. PubMed ID: 2033266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
